Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Atara Biotherapeutics (ATRA) Change in Acquisitions & Divestments (2022 - 2025)

Historic Change in Acquisitions & Divestments for Atara Biotherapeutics (ATRA) over the last 4 years, with Q3 2025 value amounting to $1000.0.

  • Atara Biotherapeutics' Change in Acquisitions & Divestments fell 9996.67% to $1000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $20.7 million, marking a year-over-year decrease of 4105.2%. This contributed to the annual value of $28.5 million for FY2024, which is 8632.81% down from last year.
  • Latest data reveals that Atara Biotherapeutics reported Change in Acquisitions & Divestments of $1000.0 as of Q3 2025, which was down 9996.67% from $17.2 million recorded in Q1 2025.
  • In the past 5 years, Atara Biotherapeutics' Change in Acquisitions & Divestments registered a high of $89.2 million during Q1 2022, and its lowest value of $1000.0 during Q3 2025.
  • In the last 4 years, Atara Biotherapeutics' Change in Acquisitions & Divestments had a median value of $33.9 million in 2022 and averaged $39.1 million.
  • Examining YoY changes over the last 5 years, Atara Biotherapeutics' Change in Acquisitions & Divestments showed a top increase of 1586.5% in 2025 and a maximum decrease of 9996.67% in 2025.
  • Over the past 4 years, Atara Biotherapeutics' Change in Acquisitions & Divestments (Quarter) stood at $50.7 million in 2022, then plummeted by 80.29% to $10.0 million in 2023, then crashed by 65.3% to $3.5 million in 2024, then tumbled by 99.97% to $1000.0 in 2025.
  • Its Change in Acquisitions & Divestments stands at $1000.0 for Q3 2025, versus $17.2 million for Q1 2025 and $3.5 million for Q4 2024.